Increased cyclin dependent kinase in aortic tissue of rats fed homocysteine

Thrombosis and Haemostasis

Volumn 75, Issue 4, 1996, Pages 542-545

  Lubec, Barbara ^a   Arbeiter, Klaus ^a   Hoeger, Harald ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE; HOMOCYSTEIC ACID; HOMOCYSTEINE; HYDROXYPROLINE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY OCCLUSION; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HOMOCYSTINURIA; MITOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029869178     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650317     Document Type: Article

References (29)

1. Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia - A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-6.
2. Boers GHJ, Smals AG, Trijbels FJ. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 316: 725-30.
3. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Circulation 1989; 79: 1180-8.
4. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, De Garmo P. Elevated plasma homocyst(e)ine in acute stroke and TIA: A possible risk factor for stroke. Stroke 1990; 21: 572-6.
5. Clarke R, Kaly L, Robinson K, Naughten E, Calahane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
6. Brattstrom LE, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamerfeldt A. Hyperhomocysteinemia in stroke - Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22: 214-21.
7. Crawford DW; Blankenhorn DH. Arterial wall oxygenation, oxyradicals and atherosclerosis. Atherosclerosis 1991; 89: 97-108.
8. Starkebaum G, Harlan JM. Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370-6.
9. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Single D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-18.
10. Frauscher G, Karnaukhova E, Muehl A, Hoeger H, Lubec B. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid - Additional mechanisms in homocysteine induced endothelial damage? Life Sci 1995; 57: 813-7.
11. Mao Y, Lubec G, Getoff N, Solar S, Quint RM. The effect of homocysteine thiolactone and its alpha-alkylated derivatives on the survival of irradiated E. coli AB II57. Rad Phys Chem 1994; 44: 473-8.
12. Lubec B, Szekeres Th. Growth promotion by homocysteine thiolactone and its alpha-alkylated derivative. Amino Acids 1994; 7: 109-11.
13. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369-73.
14. Doree M, Galas S. The cyclin dependent protein kinases and the control of cell division. FASEB J 1994; 8: 1114-21.
15. Fermo I, Arcelloni E, De Vecchi S, Vigano S, Paroni R. High performance liquid chromatography method with fluorescence detection for the determination of total homocyst(e)ine in plasma. J Chromatogr 1992; 593: 171-6.
16. Khaidar A, Marx M, Lubec B, Lubec G. L-arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 1994; 90: 479-83.
17. Woessner JF. Determination of hydroxyproline in tissue and protein sample containing small proportion of this amino acid. Arch Biochem Biophys 1961; 93: 440-7.
18. Draetta G, Beach D, Moran E. Synthesis of p34, the mammalian homolog of the yeast cdc2sup+CDC28 protein kinase, is stimulated during adenovirus induced proliferation of primary baby rat kidney cells. Oncogene 1988; 6: 553-7.
19. Labbe JC, Lee MG, Nurse P, Picard A, Doree M. Activation at M-phase of a protein kinase encoded by a starfish homologue of the cell cycle control gene cdc2sup+. Nature 1988; 335: 251-4.
20. Riabowol K, Draetta G, Brizuela L, Vandre D, Beach D. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 1989; 57: 393-401.
21. McGowan CH, Russell P, Reed SI. Periodic biosynthesis of the human M-phase promoting factor catalytic subunit p34 during the cell cycle. Mol Cell Biol 1990; 10: 3847-51.
22. Lucas JJ, Terada N, Szepesi A, Gelfand EW. Regulation of synthesis of p34(cdc2) and its homologues and their relationship to p110(Rb) phosphorylation during cell cycle progression of normal human T cells. J Immunol 1992; 148: 1804-11.
23. Dutta A, Stillman B. Cdc2 family kinases phosphorylate a human cell DNA replication factor. RPA and activate DNA replication. EMBO J 1992; 11: 2189-99
24. Stern H. Sulphhydryl groups and cell division. Science 1956; 124: 1292-3.
25. Mazia D Biochemistry of the dividing cell. Ann Rev Biochem 1961; 30: 669-88.
26. Majors AK, Erhard LA, Bezacka EH. A link between homocysteinemia and atherosclerosis: Enhanced collagen synthesis and accumulation by arterial smooth muscle cells exposed to homocysteine. Irish J Med Sci 1995; 164: 15 (abstract)
27. Shiekhattar R, Mermelstein F, Fisher RP, Drapkin R, Dynlacht B, Wessling HC, Morgan DO, Reinberg D. Cdk activating kinase complex is a component of human transcription factor TFIIH. Nature 1995; 374: 283-7.
28. Zhou W, Takuwa N, Kumada M, Takuwa Y. E2F1, B-myb and selective members of the cyclin/cdk subunits are targets for protein kinase C mediated bimodal growth regulation in vascular endothelial cells. Biochem Biophys Res Comm 1994; 199: 191-8.
29. Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Lingerland J. GI control in mammalian cells. J Cell Sci 1994; 18: 69-73.